Wire · opportunities
Neurotronics Receives FDA Clearance for Sleep Analysis Module, Advancing Nihon ...
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 3 November 2026 · Fusion42 review
Neurotronics has received FDA 510(k) clearance for its Sleep Analysis Module (SAM), a software-only device that estimates total sleep time from pulse oximetry signals, enhancing sleep disorder diagnostics without additional hardware. SAM will be integrated into Neurotronics' existing sleep diagnostic software and home sleep apnea testing solution, enabling more accurate evaluation of sleep apnea severity using AI/ML algorithms.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.
◆ ◆ The Wire takeaway
You must adapt your sleep disorder tools to incorporate AI-driven metrics from standard pulse oximetry signals. This cleared software module lowers barriers to more precise sleep assessments, sidestepping extra hardware and simplifying clinical workflows.
◆ Coverage
1 source · 3 Nov 2026
◆ Related on Wire
◆ Topics